InsidersTradesSigma
Total declarations
Company
▲ Purchases (7 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Thompson Jaye. Insider active across 1 companies, notably Greenwich LifeSciences, Inc.. In total, 7 reports have been published. Total volume traded: €74k. The latest transaction was filed on 19 April 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations7 total
€7,754500 shares@ €15.50790.0021% mcap10.5% of flow
Common Stock
SEC:0001493152-22-010484:0·
Ideal exit: 14 Jan 2023 (T+270)
€8,281500 shares@ €16.56150.0022% mcap25.1% of flow
Common Stock
SEC:0001493152-22-002817·
Ideal exit: 28 Oct 2022 (T+270)
€8,281500 shares@ €16.56150.0022% mcap11.2% of flow
Common Stock
SEC:0001493152-22-002817:0·
Ideal exit: 28 Oct 2022 (T+270)
€7,217500 shares@ €14.43380.0019% mcap21.9% of flow
Common Stock
SEC:0001493152-22-002021·
Ideal exit: 18 Oct 2022 (T+270)
€7,217500 shares@ €14.43380.0019% mcap9.8% of flow
Common Stock
SEC:0001493152-22-002021:0·
Ideal exit: 18 Oct 2022 (T+270)
€17,4711,000 shares@ €17.47130.0046% mcap53.0% of flow
Common Stock
SEC:0001493152-22-001189·
Ideal exit: 10 Oct 2022 (T+270)
€17,4711,000 shares@ €17.47130.0046% mcap23.7% of flow
Common Stock
SEC:0001493152-22-001189:0·
Ideal exit: 10 Oct 2022 (T+270)
7 of 7 declarations
About Thompson Jaye
Jaye Thompson is a director at Greenwich LifeSciences, Inc.
